Drug firm Wockhardt today reported a consolidated net loss of Rs 191. 64 crore for the quarter ended March 31 2012 burdened by exceptional items
Drugmakers Ind-Swift and Wockhardt have jointly launched a generic version of Pfizer's cholesterol lowering drug Lipitor in the United Kingdom, the two companies said.
The copycat version was launched on
Shares of drug firm Wockhardt Ltd today rose by 8 per cent after the company's profit increased by 50. 21 per cent for the quarter ended December 31 2011
Drug firm Wockhardt Ltd today said its consolidated net profit rose by 50. 21 per cent to Rs 212
Drug firm Wockhardt today said it has received final approval from the US health regulator to market generic Fluticasone nasal spray, used for treating allergic nasal inflammation, in the American
Drug firm Wockhardt plans to launch 12-15 products in the US market this fiscal and also increase its reach in the European market.
"The company received 7 abbreviated new drug
Wockhardt expects to complete divestment of its nutrition business by the end of this financial year. The company said it has reached agreement with EU based secured lenders
Drug firm Wockhardt today posted a consolidated net profit of Rs 194 crore for the first quarter ended June 30, 2011.
The company had reported a net loss of Rs
Stay informed on our latest news!